D. Januszkiewicz

发表

Multiple sclerosis-associated virus-related pol sequences found both in multiple sclerosis and healthy donors are more frequently expressed in multiple sclerosis patients

K. Lewandowski, H. Hertmanowska, M. Zawada, 2011, Journal of NeuroVirology.

Activity and expression of human telomerase in normal and malignant cells in gastric and colon cancer patients

J. Wysocki, K. Lewandowski, J. Nowak, 2003, European journal of gastroenterology & hepatology.

Limited junctional diversity of Vδ5-Jδ1 rearrangement in multiple sclerosis patients

M. Wender, D. Januszkiewicz, G. Michałowska-Wender, 1997 .

Restricted T cell receptor delta chain genes repertoire in peripheral blood of multiple sclerosis patients

G. Przybylski, M. Wender, D. Januszkiewicz, 1996 .

Thiopurine S‐methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6‐mercaptopurine doses during maintenance therapy: The Polish multicenter analysis

W. Młynarski, M. Droździk, M. Kurzawski, 2011, Pediatric blood & cancer.

Hepatitis B and C virus infection in Polish children with malignancies

J. Wysocki, D. Januszkiewicz, J. Nowak, 1997, European Journal of Pediatrics.

Detection of clonality by polymerase chain reaction in childhood B-lineage acute lymphoblastic leukemia

D. Januszkiewicz, J. Nowak, 1994, Annals of Hematology.

Impact of heterozygous c.657-661del, p.I171V and p.R215W mutations in NBN on nibrin functions.

A. Dzikiewicz-Krawczyk, D. Januszkiewicz, M. Mosor, 2012, Mutagenesis.

No evidence for association of the polymorphisms in NLRP1 gene with type 1 diabetes in Poland.

P. Fichna, M. Fichna, J. Nowak, 2011, Diabetes research and clinical practice.

Cumulative effect of IFIH1 variants and increased gene expression associated with type 1 diabetes.

P. Fichna, A. Dzikiewicz-Krawczyk, B. Skowrońska, 2015, Diabetes research and clinical practice.

Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase.

K. Lewandowski, M. Zawada, J. Nowak, 2006, Oncology reports.

Gene Therapy of Human Melanoma — from Animal Experiments to the Clinical Trial

P. Murawa, J. Malicki, M. Wiznerowicz, 1997 .

Polymorphic variant at the IL2 region is associated with type 1 diabetes and may affect serum levels of interleukin-2

P. Fichna, Iwona Ziółkowska-Suchanek, M. Fichna, 2013, Molecular Biology Reports.

Polymorphic variants of the IL2RA gene and susceptibility to type 1 diabetes in the Polish population.

P. Fichna, M. Fichna, J. Nowak, 2012, Tissue antigens.

Juvenile xanthogranuloma with clonal proliferation in the bone marrow.

E. Mały, J. Nowak, D. Januszkiewicz, 2012, Journal of pediatric hematology/oncology.

Telomerase as a marker of tumour development - analysis of telomerase expression and activity

K. Lewandowski, J. Nowak, D. Januszkiewicz, 2000 .

Lack of correlation between telomere length and telomerase activity and expression in leukemic cells.

K. Lewandowski, J. Nowak, D. Januszkiewicz, 2003, International journal of molecular medicine.

Limited pattern of TCR delta chain gene rearrangement on the RNA level in multiple sclerosis.

K. Lewandowski, H. Hertmanowska, M. Wender, 2001, Journal of applied genetics.

Molecular evidence for central nervous system involvement in children with newly diagnosed acute lymphoblastic leukemia

D. Januszkiewicz, J. Nowak, 1995, Hematological oncology.

Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours.

R. Słomski, A. Pławski, D. Januszkiewicz, 2008, European journal of cancer.

Is the NBN Gene Mutation I171V a Potential Risk Factor for Malignant Solid Tumors in Children?

D. Januszkiewicz, J. Rembowska, K. Nowicka, 2011, Journal of pediatric hematology/oncology.

Polymorphisms in the interferon‐induced helicase (IFIH1) locus and susceptibility to Addison's disease

P. Fichna, M. Fichna, J. Nowak, 2013, Clinical endocrinology.

Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours.

R. Słomski, A. Pławski, D. Januszkiewicz, 2008, European journal of cancer.